Clinical trial
To Determine the Effect of Forlax® Treatment in Children With Chronic…
NCT00255372 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00255372 |
|---|---|
| Title | To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence. |
| Official title | Polyethylene Glycol Laxative (Macrogol 4000;Forlax®) for Treatment of Chronic Constipation in Children : A Phase III, Bicentric, Randomized, Double-blind, Lactulose Controlled Study. |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Constipation |
| Intervention type | Drug |
| Interventions | PEG 4000 (Forlax®), Lactulose active and Lactulose placebo |
| Enrollment | 88 |
| Start date | Apr 1, 2005 |
| Primary completion | May 20, 2008 |
| Completion | May 20, 2008 |
| First posted | Nov 18, 2005 |
| Last update posted | Apr 24, 2020 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: